sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Aprotinin Market Growth 2019-2024

Global Aprotinin Market Growth 2019-2024

Home / Categories / Healthcare
Global Aprotinin Market Growth 2019-2024
Global Aprotinin Market Growth 2019-2024
Report Code
RO1/109/1631

Publish Date
13/Feb/2019

Pages
165
PRICE
$ 3660/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5490/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7320/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Currently, there are many sales companies in the world Aprotinin industry, especially in India and China. The main market players are Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited and Guangdong Techpool Bio-pharma. The sale Revenue of Aprotinin is about 123458 K USD in 2015.

North America is the largest consumption region of Aprotinin, with a Revenue market share nearly 20.28% in 2015.

The second consumption place is Europe; following North America with the Revenue market share of 19.66%. China is another important market of Aprotinin, enjoying 17.23% Revenue market share.

Aprotinin is used in Pharmaceuticals and Scientific Research & Experiment areas. Report data showed that 74.04% of the Aprotinin market demand in Pharmaceuticals and 25.96% in Scientific Research & Experiment areas in 2015.

There are three kinds of Aprotinin, which are Aprotinin (From bovine lung) and Recombinant Aprotinin. Aprotinin (From bovine lung) is wildly used in the Aprotinin, with a revenue market share nearly 81.11% in 2015.

Briefly speaking, in the next few years, Aprotinin industry will still be a highly energetic industry. Sales of Aprotinin have brought a lot of opportunities, there will more companies enter into this industry, especially in developing countries.


According to this study, over the next five years the Aprotinin market will register a 4.7% CAGR in terms of revenue, the global market size will reach USD 180 million by 2024, from USD 140 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Aprotinin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Aprotinin market by product type, application, key manufacturers and key regions and countries.

This study considers the Aprotinin value and volume generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Aprotinin (From bovine lung)
Recombinant Aprotinin
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pharmaceuticals
Scientific Research & Experiment

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Aprotinin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Aprotinin market by identifying its various subsegments.
Focuses on the key global Aprotinin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Aprotinin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Aprotinin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com